Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
CRVS | Corvus Pharmaceuticals, Inc. | President and CEO, Director | $3.06M | +$1M | +48.6% | Dec 20, 2024 |
BOLT | Bolt Biotherapeutics, Inc. | Director | Jun 12, 2023 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|